| Symbol | DYAI |
|---|---|
| Name | DYADIC INTERNATIONAL INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 1044 NORTH U.S. HIGHWAY ONE, JUPITER, FL 33477 |
| Telephone | 561-743-8333 |
| Fax | — |
| — | |
| Website | https://www.dyadic.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001213809 |
| Description | Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries. Additional info from NASDAQ: |
New Form PRE 14A - DYADIC INTERNATIONAL INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001493152-26-020913 <b>Size:</b> 3 MB
Read moreNew Form 10-K/A - DYADIC INTERNATIONAL INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020402 <b>Size:</b> 911 KB
Read moreDyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026
Read moreDyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Read moreDyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Read more(30% Negative) DYADIC INTERNATIONAL INC (DYAI) Reports Q1 2026 Financial Results
Read moreNew Form 10-K - DYADIC INTERNATIONAL INC <b>Filed:</b> 2026-03-25 <b>AccNo:</b> 0001493152-26-012672 <b>Size:</b> 8 MB
Read moreDyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
Read moreDyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
Read moreDyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
Read more